These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22722516)

  • 21. Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial.
    Richter C; Hinzpeter A; Schmidt F; Kienast T; Preuss UW; Plenge T; Heinz A; Schaefer M
    J Clin Psychopharmacol; 2010 Dec; 30(6):720-5. PubMed ID: 21105289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
    Likhitsathian S; Uttawichai K; Booncharoen H; Wittayanookulluk A; Angkurawaranon C; Srisurapanont M
    Drug Alcohol Depend; 2013 Dec; 133(2):440-6. PubMed ID: 23906999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
    Handforth A; Martin FC
    Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.
    Croissant B; Diehl A; Klein O; Zambrano S; Nakovics H; Heinz A; Mann K
    Alcohol Clin Exp Res; 2006 Apr; 30(4):630-5. PubMed ID: 16573580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF; Banerjee S; Brabant Y; Helmers S
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial.
    Alho H; Methuen T; Paloheimo M; Strid N; Seppä K; Tiainen J; Salaspuro M; Roine R
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1816-22. PubMed ID: 12500105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA; Hurwitz S; Bromfield EB
    Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam in social phobia: a placebo controlled pilot study.
    Zhang W; Connor KM; Davidson JR
    J Psychopharmacol; 2005 Sep; 19(5):551-3. PubMed ID: 16166192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.